GTC Global
Sep 71 min read
Amgen v. Commissioner: Functional Analysis Back at the Centre of Transfer Pricing Disputes
June 2026 An ongoing U.S. case is testing how far the IRS can go in restructuring a multinational's intercompany licence arrangements, and how much weight recent appellate reasoning should carry in that analysis. The case, Amgen Inc. v. Commissioner, concerns the pricing of intercompany licences between the pharmaceutical group's U.S. parent and its Puerto Rican manufacturing affiliate. The IRS argues that the arrangement understated the return owed to the U.S. entity, which

